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Colorectal Carcinoma (CRC) is a heterogeneous disease
with different molecular characteristics associated with the
sites from which, the tumours originate. Such heterogeneity
is compounded by the multitude of genetic and epigenetic
variations acting as passengers or drivers of the tumour.
Majority of CRC develops via chromosomal instability
(CIN) pathway. CIN is often exacerbated by inactivation of
the Wnt signalling pathway “master regulator” APC gene,
activating mutations of KRAS or BRAF oncogenes, or
deletions of the 18q, and 17p chromosomal regions with
deleterious effects on the tumour suppressor genes TP53
and DCC. Defective Mismatch Repair (MMR) pathway
results in a subtler form of genomic instability, namely
Microsatellite Instability (MSI). High levels of MSI (or
MSI-H) in sporadic CRC are usually caused by hyper-
methylation of the MLH1 promoter. In terms of methyla-
tion, the CpG island methylator phenotype (CIMP)
pathway is the second most common pathway in sporadic
CRC. CIMP-positive (CIMPp) CRC tumours are usually
associated with the proximal colon of older females.
CIMPp CRC tumours have better prognosis if the tumours
are also MSI-H. However, CIMPp CRC tumours that are
Microsatellite Stable (MSS) have poor clinical outcome.
To gain insight into the molecular mechanisms underpin-
ning CRC in Saudi Arabian patients, we profiled the DNA
methylation frequency of key genes (MLH1, MSH2,
RASSF1A, SLIT2, HIC1, MGMT, SFRP1, MYOD1, APC,
CDKN2A, and other five CIMP markers) in 120 sporadic
CRC cases. CRC tumours originating from the rectum,
left, and right colons are represented in this cohort.
Expression patterns of different proteins playing important
role in CRC carcinogenesis also studied by using Immuno-
histochemistry (IHC) technique and their impact as
CRC prognosticators was evaluated.
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